Abstract
Multiple sclerosis (MS) is a chronic progressive autoimmune disease of the central nervous system (CNS). The health-related quality of life (HRQoL) of MS patients is significantly impacted by the pathophysiology and symptomatology of the disease. However, limited national-level data exists regarding the HRQoL of MS patients. This study evaluated the HRQoL and functional limitations of MS patients using the 2006-2015 Medical Expenditure Panel Survey (MEPS).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
